Incyte (INCY) Cash from Financing Activities (2010 - 2026)

Incyte (INCY) posted Cash from Financing Activities of $84.8 million for Q1 2026, down 38.42% on a QoQ basis from $137.7 million in Q4 2025, and up 769.15% year-over-year from $9.8 million in Q1 2025.

Incyte (INCY) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Incyte's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at $84.8 million for Q1 2026.

  • Quarterly Cash from Financing Activities rose 769.15% year-over-year to $84.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $198.5 million (up 109.82% YoY) and the FY2025 annual result came in at $101.0 million, up 105.0% from the prior year.
  • Cash from Financing Activities was $84.8 million for Q1 2026 at Incyte, down from $137.7 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $137.7 million in Q4 2025 and bottomed at -$2.0 billion in Q2 2024.
  • A 5-year average of -$109.2 million and a median of -$2.5 million in 2022 frame the typical range for Cash from Financing Activities.
  • Peak annual rise in Cash from Financing Activities reached 5794.22% in 2024, while the deepest fall reached 15620.49% in 2024.
  • Incyte's Cash from Financing Activities stood at -$2.5 million in 2022, then surged by 113.95% to $346000.0 in 2023, then surged by 5794.22% to $20.4 million in 2024, then surged by 575.39% to $137.7 million in 2025, then tumbled by 38.42% to $84.8 million in 2026.
  • Business Quant data shows INCY's Cash from Financing Activities at $84.8 million in Q1 2026, $137.7 million in Q4 2025, and -$12.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Incyte 23.33 Bn 19.32 Bn 1.17 Bn 84.82 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 84.82 Mn
Mar 31, 2026 84.82 Mn
Dec 31, 2025 137.74 Mn
Dec 31, 2025 137.74 Mn
Sep 30, 2025 -12.78 Mn
Sep 30, 2025 -12.78 Mn
Jun 30, 2025 -11.25 Mn
Jun 30, 2025 -11.25 Mn
Mar 31, 2025 -12.68 Mn
Mar 31, 2025 -12.68 Mn
Dec 31, 2024 20.39 Mn
Dec 31, 2024 20.39 Mn
Sep 30, 2024 -32.35 Mn
Sep 30, 2024 -32.35 Mn
Jun 30, 2024 -2.00 Bn
Jun 30, 2024 -2.00 Bn
Mar 31, 2024 -12.41 Mn
Mar 31, 2024 -12.41 Mn
Dec 31, 2023 346,000.00
Dec 31, 2023 346,000.00